Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Shell Contract Consolidates Top Tier Global Energy Position September 11, 2025 Corporate Presentation September 11, 2025 Two Pools Project expands with new tenement applications September 11, 2025